Gastrin-releasing peptide precursor, also known as pro-gastrin-releasing peptide (ProGRP), is a neuropeptide that has been found to be specifically elevated in SCLC patients and correlates with disease extent and prognosis (9, 10). This evidence concerns the gene GAST and small cell lung carcinoma.